fertility-health
Thyroid Disorders and Fertility: How Hypothyroidism and Hyperthyroidism Affect Conception
Dr. Carolina Gallardo
Blocked Fallopian Tubes
Blocked fallopian tubes prevent natural conception, but IVF bypasses the tubes entirely — and for hydrosalpinx specifically, salpingectomy before IVF dramatically improves success rates.
Tubal factor infertility accounts for 25–30% of all female infertility cases
Fallopian tubes can be blocked at the proximal (uterine) end, mid-segment, or distal (fimbrial) end — each with different causes and treatmentsHydrosalpinx (fluid-filled, dilated tube) reduces IVF live birth rates by approximately 50% and must be treated before IVFHysterosalpingogram (HSG) is the standard first-line screening test; laparoscopy with chromotubation remains the gold standard for diagnosisBilateral tubal occlusion requires IVF; unilateral occlusion allows natural conception through the patent tubePelvic inflammatory disease (PID) — most commonly from Chlamydia trachomatis — is the leading cause of tubal infertility worldwide
Find Clinics That Specialize in Blocked Fallopian TubesHow Blocked Fallopian Tubes Affects Fertility
The fallopian tubes serve two essential reproductive functions: they are the site of fertilization (where sperm meets egg in the ampullary segment) and they transport the early embryo to the uterus over 3–5 days via ciliary action and smooth muscle peristalsis. When a tube is blocked, fertilization cannot occur naturally — sperm cannot reach the egg, or the fertilized egg cannot travel to the uterus. Complete bilateral occlusion eliminates the possibility of spontaneous conception entirely. Unilateral occlusion reduces the functional ovarian-tube pairing to one side and halves the monthly probability of conception, but natural pregnancy remains possible.
The most common causes of tubal blockage include pelvic inflammatory disease (PID) from ascending genital tract infection — particularly Chlamydia trachomatis and Neisseria gonorrhoeae, which trigger fallopian tube scarring and adhesion formation; prior pelvic surgery (appendectomy, ovarian cystectomy, myomectomy) causing peritoneal adhesions; endometriosis with tubal involvement; and prior ectopic pregnancy with tubal damage or surgical removal. Congenital tubal abnormalities are rare. Proximal tubal occlusion (at the uterine cornua) detected on HSG is frequently a false positive due to tubal spasm — selective salpingography or hysteroscopic cannulation can confirm or exclude true obstruction.
Hydrosalpinx — a distally blocked tube that has become distended with fluid — has a uniquely detrimental effect on IVF success that extends beyond simple mechanical blockage. The hydrosalpinx fluid is embryotoxic, containing inflammatory cytokines, bacteria-derived endotoxins, and reactive oxygen species. When this fluid refluxes into the uterine cavity, it directly impairs endometrial receptivity and embryo implantation. A landmark meta-analysis (Camus et al., Hum Reprod 1999; confirmed by Strandell et al., RCT 2001) demonstrated that hydrosalpinx reduces IVF live birth rates by approximately 50%. The ASRM and ESHRE both recommend surgical treatment of hydrosalpinx — either salpingectomy (tube removal) or proximal tubal occlusion — before IVF. Salpingectomy is preferred when feasible, as it eliminates the hydrosalpinx fluid source entirely.
Treatment Options
Treatment is individualized based on age, severity, duration of infertility, and partner factors. Work with your reproductive endocrinologist to determine the right sequence for your specific situation.
First-line treatment
Salpingectomy or Proximal Tubal Occlusion Before IVF (Hydrosalpinx)
For women with hydrosalpinx planning IVF, surgical treatment is mandatory — not optional. Laparoscopic salpingectomy (removal of the tube) eliminates the fluid reservoir and restores IVF live birth rates to those expected without hydrosalpinx. An RCT by Strandell et al. (Hum Reprod 2001) found a near-doubling of live birth rates after salpingectomy (36.6% vs. 23.9%) compared to no surgery. Proximal tubal ligation or Filshie clip occlusion is an alternative when salpingectomy is technically difficult due to adhesions. Ultrasound-guided aspiration of hydrosalpinx fluid is a temporary measure with high recurrence rates and is not equivalent to surgical treatment.
Typical success rate
IVF live birth rates restored to ~35–45% per transfer after salpingectomy (vs. ~20–25% with untreated hydrosalpinx)
First-line treatment
IVF (In Vitro Fertilization)
IVF bypasses the fallopian tubes entirely: eggs are retrieved directly from ovarian follicles by transvaginal aspiration under ultrasound guidance, fertilized in the laboratory, and embryos are transferred directly into the uterine cavity. For bilateral tubal occlusion, IVF is the definitive treatment and achieves excellent outcomes when the underlying cause has been addressed. For unilateral occlusion, IVF may be recommended over expectant management if the patient is older or has been trying unsuccessfully for 12 months. IVF is the treatment of choice for most tubal factor patients, particularly those over 35 or with concurrent male factor.
Typical success rate
35–45% live birth per embryo transfer for women under 38 with tubal factor (SART 2022)
Tubal Surgery (Tubal Anastomosis or Salpingostomy)
Microsurgical tubal anastomosis is performed to reverse a prior tubal ligation (sterilization reversal) — success rates of 50–80% cumulative pregnancy are achieved within 12–18 months, making it competitive with IVF in younger women (under 37) with a good-length remaining tube segment. Salpingostomy (surgical opening of a distally blocked tube) to treat hydrosalpinx is generally not recommended over IVF due to high re-occlusion rates (30–60% at 1 year) and ectopic pregnancy risk. Proximal tubal cannulation (using a catheter under fluoroscopic or hysteroscopic guidance) can treat true proximal occlusion with a 50–70% patency rate and 30–40% cumulative pregnancy rate.
Typical success rate
Sterilization reversal: 50–80% cumulative pregnancy at 12–18 months (varies by remaining tube length and age)
Hysteroscopic Tubal Cannulation (Proximal Occlusion)
For women with proximal tubal occlusion (near the uterus), hysteroscopic or fluoroscopic cannulation uses a fine catheter to open the blocked segment from within the uterus. It achieves tubal patency in 70–90% of cases of true proximal obstruction and subsequent pregnancy rates of 30–50% within 12 months. It is appropriate for women who prefer to avoid IVF, are under 35, and whose proximal obstruction has been confirmed (ruling out spasm). Re-occlusion occurs in 30–50% within 2 years.
Typical success rate
30–50% cumulative pregnancy within 12 months of successful cannulation
What Patients with Blocked Fallopian Tubes Can Expect
IVF is the most effective treatment for bilateral tubal factor infertility and achieves outcomes comparable to other infertility diagnoses when the underlying cause (particularly hydrosalpinx) has been surgically addressed. Tubal surgery is a viable alternative for sterilization reversal in young women or proximal occlusion, but IVF is generally preferred for women over 37 or those with concurrent infertility factors.
| Treatment | Typical Success Range |
|---|---|
| IVF with untreated hydrosalpinx | ~20–25% live birth per transfer |
| IVF after salpingectomy (hydrosalpinx) | 35–45% live birth per transfer |
| IVF (bilateral tubal occlusion, no hydrosalpinx) | 35–45% live birth per transfer, age < 38 |
| Sterilization reversal (age < 37, good tube length) | 50–80% cumulative pregnancy at 12–18 months |
| Hysteroscopic cannulation (proximal occlusion) | 30–50% cumulative pregnancy at 12 months |
Individual outcomes vary significantly based on age, ovarian reserve, partner factors, and clinic expertise. These figures are based on published research (ASRM, SART, Cochrane Reviews) and national averages — they are not guarantees. Ask your clinic for their own reported outcomes for your specific diagnosis and age group.
Questions to Ask Your Reproductive Endocrinologist
Bring this list to your first consultation to make the most of your appointment.
- 1
Do I have unilateral or bilateral tubal occlusion, and which part of the tube is blocked?
- 2
Is a hydrosalpinx present, and do you recommend salpingectomy or proximal occlusion before IVF?
- 3
Was my HSG finding confirmed at laparoscopy, or could the proximal blockage be spasm?
- 4
Am I a candidate for tubal surgery rather than IVF, given my age and the cause of blockage?
- 5
If I am considering tubal ligation reversal, what is my prognosis based on my age and remaining tube length?
- 6
What IVF live birth rates does your clinic achieve for tubal factor infertility at my age?
When to See a Specialist
Women with a known history of PID, ectopic pregnancy, pelvic surgery, or STI should have tubal patency assessed (HSG) before trying to conceive, rather than after 12 months of failure. Any HSG showing unilateral or bilateral occlusion should prompt immediate reproductive endocrinology referral. A hydrosalpinx finding requires urgent consultation — surgical treatment before IVF is time-sensitive.
Ready to Find a Clinic That Specializes in Blocked Fallopian Tubes?
Look for clinics with reproductive endocrinologists (REs) who have documented experience treating Blocked Fallopian Tubes. Ask about their specific outcomes for your diagnosis and age group during your first consultation — outcomes vary significantly by clinic.
Select your state to browse fertility clinics near you:
Related Articles
IVF
Beta hCG After IVF: What Your First Result Means
Your first beta hCG result after IVF is one of the most nerve-wracking numbers in the entire process. This guide explains what it means, what doubling times to expect, how to interpret a borderline result, and what comes next.
Dr. Hannah Ní Bhriain Russell
IVF
OHSS After IVF: Symptoms, Classification, Prevention & Treatment
Ovarian hyperstimulation syndrome is the most serious complication of IVF stimulation. This guide covers who is at risk, how severity is graded, evidence-based prevention strategies, and what to do if symptoms develop.
Dr. Hannah Ní Bhriain Russell
Fertility Treatment
Adenomyosis and Fertility — IVF Outcomes & Treatment
Adenomyosis — endometrial tissue invading the uterine muscle — impairs implantation and raises miscarriage risk. This guide covers MRI diagnosis, GnRH agonist pretreatment, freeze-all IVF strategy, and realistic success rate expectations.
Dr. Hannah Ní Bhriain Russell
Related Conditions
Polycystic Ovary Syndrome (PCOS)
Affects 1 in 10 women of reproductive age (6–12% globally)
Learn moreEndometriosis
Affects ~10% of reproductive-age women; up to 50% of infertile women
Learn moreUnexplained Infertility
Diagnosed in 15–30% of infertile couples after standard evaluation
Learn moreRecurrent Pregnancy Loss (RPL)
Affects 1–2% of couples; recurrence risk rises sharply after 3 or more losses
Learn more